AQUESTIVE THERAPEUTICS
5.0900
20-September-24 15:59:59
15 minutes delayed
Stocks
-0.1100
-2.12%
Today's range
5.0550 - 5.2900
ISIN
N/A
Source
NASDAQ
-
Aquestive Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
02 May 2023 16:31:30 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
26 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
20 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
18 Apr 2023 08:00:02 By Nasdaq GlobeNewswire
-
29 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
07 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Oppenheimer 33rd Annual Healthcare Conference
01 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
22 Feb 2023 08:00:56 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives
06 Jan 2023 08:00:00 By Nasdaq GlobeNewswire
-
22 Dec 2022 08:00:00 By Nasdaq GlobeNewswire
-
29 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
15 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
01 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Licenses Sympazan® (clobazam) Oral Film to Assertio Holdings, Inc.
27 Oct 2022 09:05:24 By Nasdaq GlobeNewswire
-
24 Oct 2022 08:00:00 By Nasdaq GlobeNewswire
-
19 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
11 Oct 2022 08:00:01 By Nasdaq GlobeNewswire